Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-08-28
1986-04-15
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514260, A61K 3150, A61K 31495, A61K 31505
Patent
active
045828326
ABSTRACT:
The use of trimazosin or a pharmaceutically acceptable acid addition salt thereof as an agent for retarding the development of atherosclerosis in a mammal, especially for retarding and reducing the development of fibrous plaques associated with atherosclerosis.
REFERENCES:
patent: 3669968 (1972-06-01), Hess
patent: 4130647 (1978-12-01), Taylor
patent: 4150119 (1979-04-01), Lalinde
patent: 4245097 (1981-01-01), Shepherd
Frost Albert E.
Knuth Charles J.
Lipovsky Joseph A.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Trimazosin as an anti-atherosclerosis agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trimazosin as an anti-atherosclerosis agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trimazosin as an anti-atherosclerosis agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1439111